
Psychedelic Stocks
Psychedelics, such as psilocybin and DMT, are a class of powerful psychoactive substances that affect mood and cognitive processes. While still federally illegal under U.S. law, some states have voted to partially decriminalize the substances. Meanwhile, companies like ATAI Life Sciences and Compass Pathways have taken the initiative of developing psychedelic drugs to treat disorders like PTSD and depression.

7 Psychedelics Stocks to Buy for a Big Drug Boom
These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments

Don’t Miss the Boom: 3 Psychedelic Stocks Set to Explode Higher
Despite the stigma surrounding psychedelics for personal use, controlled medical experiments indicate their usefulness for treating a variety of conditions.

Hidden Gems: 3 Cannabis Stocks Flying Under the Radar
These are the overlooked cannabis stocks to buy at attractive levels as they represent companies poised for accelerated growth.